Escalon Medical Corp.
ESMC
$0.208
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 12.25% | -5.56% | 10.72% | -21.51% | -4.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 12.25% | -5.56% | 10.72% | -21.51% | -4.54% |
| Cost of Revenue | 2.41% | -4.89% | 19.23% | -8.26% | -8.24% |
| Gross Profit | 24.78% | -6.40% | 0.94% | -34.82% | 0.65% |
| SG&A Expenses | -1.87% | -0.07% | 7.87% | 19.11% | 11.52% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.85% | -5.14% | 13.74% | 0.26% | -2.19% |
| Operating Income | 462.98% | -73.08% | -32.50% | -126.56% | -- |
| Income Before Tax | 422.41% | -51.89% | -32.26% | -127.70% | -1,171.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 422.41% | -51.89% | -32.26% | -127.70% | -1,171.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 422.41% | -51.89% | -32.26% | -127.70% | -1,171.67% |
| EBIT | 462.98% | -73.08% | -32.50% | -126.56% | -- |
| EBITDA | 555.14% | -254.35% | -26.94% | -125.45% | -612.28% |
| EPS Basic | 238.33% | -32.61% | 8,100.00% | -130.57% | -361.54% |
| Normalized Basic EPS | 423.44% | -50.00% | -32.34% | -127.79% | -1,180.00% |
| EPS Diluted | 238.33% | -117.39% | 8,100.00% | -155.53% | -361.54% |
| Normalized Diluted EPS | 270.31% | -50.00% | 25.56% | -150.55% | -1,180.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 89.90% | 0.00% | -46.34% | -44.99% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
